An announcement from Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) is now available.
Beijing Chunlizhengda Medical Instruments Co., Ltd. has released its preliminary financial results for 2024, showing a significant decline in key financial metrics. The company reported a 33.32% decrease in total operating revenue and a 57.28% drop in operating profit compared to the previous year. Net profit attributable to the parent company also fell by 55.01%, highlighting challenges in the company’s financial performance. These unaudited results suggest potential risks for investors and indicate a need for strategic adjustments to improve the company’s market positioning.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a joint stock limited company based in China, specializing in the production of medical instruments. The company operates within the healthcare industry, focusing on developing and manufacturing medical devices.
YTD Price Performance: 6.79%
Average Trading Volume: 367,859
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$5.08B
For an in-depth examination of 1858 stock, go to TipRanks’ Stock Analysis page.